AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial)
- Masdeu, Joseph C. (PI)
- Faridar, Alireza (CoI)
- Nakawah, M. Obadah (CoI)
Project: Federal Funding Agencies